Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keld Fosgerau

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|December 3, 2014
Peptide therapeutics: current status and future directionsKeld Fosgerau, Torsten Hoffmann
The Journal of Biological Chemistry|June 4, 2002
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparationsKeld Fosgerau, Jens Breinholt, James G McCormack, et al.
European Journal of Pharmacology|September 21, 2017
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetesJolanta Skarbaliene, Kristoffer T Rigbolt, Keld Fosgerau, et al.
The Journal of Endocrinology|December 25, 2015
Defective insulin secretion by chronic glucagon receptor activation in glucose intolerant miceLinda Ahlkvist, Bilal Omar, Anders Valeur, et al.
Neurochemical Research|December 13, 2005
Compartmentation of lactate originating from glycogen and glucose in cultured astrocytesHelle M Sickmann, Arne Schousboe, Keld Fosgerau, et al.
The Journal of Endocrinology|November 9, 2013
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivityKeld Fosgerau, Kirsten Raun, Cecilia Nilsson, et al.
Peptides|April 8, 2015
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF ratsJolanta Skarbaliene, Thomas Secher, Jacob Jelsing, et al.
Drug Discovery Today|July 9, 2017
Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentHenrik H Hansen, Michael Feigh, Sanne S Veidal, et al.
Diabetes|November 30, 2006
Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell functionHeidi Sørensen, Maria Sörhede Winzell, Christian L Brand, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2007
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide)Sang Won Suh, Jennifer P Bergher, Christopher M Anderson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|December 3, 2014
Peptide therapeutics: current status and future directionsKeld Fosgerau, Torsten Hoffmann
The Journal of Biological Chemistry|June 4, 2002
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparationsKeld Fosgerau, Jens Breinholt, James G McCormack, et al.
European Journal of Pharmacology|September 21, 2017
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetesJolanta Skarbaliene, Kristoffer T Rigbolt, Keld Fosgerau, et al.
The Journal of Endocrinology|December 25, 2015
Defective insulin secretion by chronic glucagon receptor activation in glucose intolerant miceLinda Ahlkvist, Bilal Omar, Anders Valeur, et al.
Neurochemical Research|December 13, 2005
Compartmentation of lactate originating from glycogen and glucose in cultured astrocytesHelle M Sickmann, Arne Schousboe, Keld Fosgerau, et al.
The Journal of Endocrinology|November 9, 2013
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivityKeld Fosgerau, Kirsten Raun, Cecilia Nilsson, et al.
Peptides|April 8, 2015
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF ratsJolanta Skarbaliene, Thomas Secher, Jacob Jelsing, et al.
Drug Discovery Today|July 9, 2017
Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentHenrik H Hansen, Michael Feigh, Sanne S Veidal, et al.
Diabetes|November 30, 2006
Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell functionHeidi Sørensen, Maria Sörhede Winzell, Christian L Brand, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2007
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide)Sang Won Suh, Jennifer P Bergher, Christopher M Anderson, et al.
Pageof 3